Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective is to demonstrate superiority with regard to overall survival (OS) of avelumab plus best supportive care (BSC) versus physician’s choice (chosen from a pre-specified list of therapeutic options) plus BSC.
Inclusion criteria
- Unresectable, recurrent, or metastatic gastric or gastroesophageal junction adenocarcinoma